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The  influence  of  the  blood  group  on the  occurrence  and  severity  of  diseases  has
aroused the curiosity of scientists for many years. The AB0 group system is the best known
and described blood group system. It is also the only system whose antibodies are constantly
present  in  the blood serum.   The most  common blood type in  Poland,  according to  data
provided by Honorary blood donation and blood therapy, is group A Rh+ (plus), while the least
common is group AB Rh– (minus).  
In studies of pregnant women scientists discovered the influence of blood type in the
development  of  preeclampsia,  gestational  diabetes,  the  risk  of  preterm  labor,  and  even
COVID-19 infection. The impact of the mothers’ blood group also affects the birth weight of
newborns,  as  well  as  the  development  of  hemolytic  disease  of  the  newborn  due  to  the
heterospecificity of AB0. The influence of the blood group on the increased risk of developing
certain diseases and complications of the neonatal period has also been proven.   
Therefore, it seems important to study blood groups of pregnant women and newborns
of different nationalities, correlate the results with available reports and use this knowledge in
everyday clinical practice. This will help to increase the speed of detection of diseases in
pregnancy and neonatal period. It will also facilitate the management of the patient depending
on their blood group.
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INTRODUCTION
ABO blood groups are defined by the carbohydrate moieties on the extracellular 
surface of the membrane of the red blood cells. AB0 antigens are also present on the surface 
of various human cells and tissues, such as epithelium, sensory neurons, thrombocytes, and 
vascular endothelium. The AB0 system was the first of the 33 currently identified blood group
systems and is the most important to transfusion medicine when testing blood donors and 
recipients for AB0 compliance. These tests are fundamental to the prevention of hemolytic 
reactions [1]. 
Currently, the issue of the influence of the blood group on the coagulation system, 
infectious diseases and cancer is being investigated. People with blood group 0 have about 
25–30% lower plasma factor VIII and von Willebrand factor levels compared to people with 
other blood groups. In addition, blood group 0 has been found to be associated with an 
increased incidence of infections with cholera, mumps and tuberculosis; type A blood group 
with an increased frequency of P. aeruginosa infection and blood group type B with a higher 
risk of gonorrhea, tuberculosis, S. pneumoniae, E. coli and Salmonella infections. Also, blood 
group AB is associated with an increased incidence of E. coli and Salmonella infections [2]. 
Other studies have shown a significant increase in the risk of stomach cancer in patients with 
blood group A compared to people with blood group 0. It has also been suspected that people 
with blood group 0 may have a reduced risk of pancreatic cancer compared to non-0 groups. 
Data from other studies show that ABO blood group is also associated with the risk of 
developing skin, ovarian and lung cancer, while it has not been found to be associated with 
colorectal and breast cancer [1]. 
COVID-19
Due to the current epidemiological situation, more and more studies raise the issue of 
factors influencing the course of SARS-CoV-2 infection. Researchers also studied the effect 
of blood type in pregnancy on COVID-19 infection. In a study conducted in September 2020, 
Ahmed et al. examined 86 pregnant women with a positive test for COVID-19 and 269 
pregnant women with a negative result. Although the largest group of pregnant women in this 
study had blood type 0, patients with blood type A had higher relative risk of contracting 
COVID-19 infection. Simultaneously, blood group 0 was associated with a lower risk of 
developing this infection. Considering that SARS-CoV-2 can replicate in epithelial cells that 
express A and B antigens in the lungs, researchers hypothesized that in people with blood type
0 who have both anti-A and anti-B antibodies this may pose a lower risk of infection [3]. 
In another study by Mirzaie et al. involving a group of 56 pregnant women diagnosed 
with COVID-19, the risk of developing COVID-19 was higher in examined patients with 
blood group AB Rh+ and 0 Rh–, than in pregnant women with other blood groups [4]. The 
above studies suggest that the blood group may have an influence on the development of 
COVID-19 infection in pregnant women, but due to limited research groups in the examples 
provided, no clear conclusions can be made regarding the groups of increased risk or 
protective effect. For this reason, and in view of the continuing pandemic situation, similar 
research should be pursued. This may contribute to better protection of pregnant women 
against this infection in the future.
PREECLAMPSIA 
One of the most serious conditions complicating pregnancy is preeclampsia. Many 
scientists have studied the relationship between AB0 blood group and preeclampsia, but their 
results are contradictory.  For this reason, many scientists are still looking for conclusive 
results on the risk and predictive factors of this condition [5–8]. Two different types of 
preeclampsia are described based on the time of onset of the disease symptoms — early and 
late-onset preeclampsia. In a study conducted by Mahasub et al. on 690 pregnant women 
(including 230 women with preeclampsia and 460 control group), blood group 0 was linked to
significantly decreased risk of late preeclampsia. Whereas in the case of early-onset 
preeclampsia, overweight/obesity and blood group 0 have been shown to be important 
independent factors associated with preeclampsia [5]. In 2016 Franchini et al. provided 
systematic literature review where they confirmed the effect of AB0 blood group on the risk 
of developing preeclampsia. In particular, it has been proved that women with a non-0 blood 
group have a slightly increased risk of this condition compared to women with blood group 0 
[6]. In another study by Phaloprakarn et al. study on 5320 pregnant women, the researchers 
found that both A and AB blood types were significantly associated with risk of preeclampsia 
[7]. However, in the study published by Uzundere et al. involving 668 pregnant women, AB0 
blood group was not strongly associated with any hypertensive disease of pregnancy [8]. 
Inconclusive results of these studies may indicate a possible influence of the blood 
group on the development of preeclampsia. However, further research in this direction will be 
required to confirm this hypothesis.
GESTATIONAL DIABETES MELLITUS (GDM)
While few studies have investigated the relationship between blood type and GDM, 
most of the results were inconsistent. An example is a hypothesis that blood group AB is a 
protective factor against GDM found in a systematic literature review presented by Franchini 
et al. [6]. This seems to be contradicted in the study involving 5320 patients by Phaloprakarn 
et al., in which the AB0 blood group was not associated with an increased risk of GDM [7]. In
another study by Sapanont et al. on 600 pregnant women it was shown that blood group 0 is 
an independent factor doubling the risk of GDM [9]. Due to limited sources, the relationship 
of the blood group to GDM cannot be clearly confirmed. However, further research may 
support or contradict the hypotheses described above. The results of subsequent analyses may 
contribute to the development of another factor influencing vigilance during screening of 
pregnant women.
BIRTH WEIGHT
Apart from its impact on the conditions of gestational period, the mother's blood group
also influences a number of neonatal complications. Scientists are trying to find the 
correlation between the mother's blood groups and the birth weight of the newborn. A total of 
2177 pregnant women was included in the Beyazit et al. study. Mothers with B blood group 
had significantly higher risk of having low birth weight babies [10]. Also, in the study by 
Gloria-Bottini et al. suggestion was made that in male neonates, the negative effect of 
smoking during pregnancy on birth weight is more visible in mothers with blood type A than 
in those with other blood groups [12]. In another study by Kothari et al., on 200 newborns the 
birth weight of AB blood group infants turned out to be significantly lower than that of the 
others. This difference was particularly noticeable in comparison to group 0 (mean birth 
weight for AB blood group was 2,62 kg and for 0 blood group 3,01 kg) [11]. These studies 
suggest that both the blood type of the mother and the newborn may influence birth weight. In
addition, other factors influencing weight gain during pregnancy, such as smoking, may also 
result in different birth weight depending on the blood group.
NEUTROPENIA AT BIRTH
Hypertensive disease of pregnancy, such as preeclampsia are associated with neonatal
neutropenia.  About  50%  of  newborns  born  to  mother  with  preeclampsia  will  develop
neutropenia [13]. Based on a study by McMahon on a group of 3,981 newborns, it was found
that  infants  with  blood  type  AB are  much  more  likely  to  develop  postnatal  neutropenia
compared to children with other blood types [14]. On another study by McMahon, after the
analysis of statistical data (1,525 newborns, 94 of whom had blood type AB), it was shown
that the probability of neutropenia is 14–89% higher for AB blood group neonates [13]. 
NEONATAL IMMUNE THROMBOCYTOPENIA (NAIT)
A  study  conducted  in  2012  confirmed  earlier  reports  that  there  is  no  correlation
between the severity of NAIT and blood group AB0. However, it has been found that blood
groups can influence the development of NAIT, although not as a primary trigger. Therefore,
the authors conclude that the association of type AB0 with the development of severe NAIT
may result from a potential association with one or more genes encoding regulatory factors
[15]. A more recent study from 2020 has shown that NAIT is more common in children of
mothers with blood type A than among children of mothers with blood type 0. Research has
also shown that some newborns with blood type A or B have platelets which contain antigens
that may be incompatible with maternal antigens. These findings  emphasize the probability
that children featuring higher AB0 antigen expression are at high risk of developing NAIT
[16]. Further studies should be performed to find out whether the AB0 antigens are related to
increased risk of the development of NAIT.
HEMOLYTIC DISEASE OF NEWBORNS
The  neonatal  hemolytic  disease  comprises  for  nearly  20%  of  neonatal  jaundice,
whereas in 30% it is caused by AB0-Rhesus incompatibility. With the widespread prevention
of Rh alloimmunisation, AB0 hemolytic disease has become more common and occurs almost
exclusively  in  blood  group  A  or  B  infants  born  to  blood  group  0  mothers  (AB0
heterospecifics) [17]. About 25% of pregnancies are heterospecific because the fetal red cells
have agglutinogen A or B absent in the mother, while maternal serum contains the appropriate
agglutinin which is antagonistic to the fetal blood group. However, only one percent of all
infants  have  clinical  signs  of  hemolytic  disease.  The  presence  of  IgG  anti-A or  anti-B
hemolysin in maternal serum is essential for the diagnosis of AB0 hemolytic disease [18]. 
Several studies have focused on maternal-fetal AB0 incompatibility and investigated
whether the newborn's blood group A or B is a serious risk factor for hemolysis and/or severe
hyperbilirubinemia. It often appeared that neonatal blood group B predisposed them to acute
hemolysis and severe hyperbilirubinemia. Transfusions were statistically more frequent in the
B0 group compared to the A0 group. In the Bel Hadj study from 2019 on a group of 98
newborns with symptomatic hemolytic disease, a significant decrease in hemoglobin levels
was noticed in the B0 group compared to the A0 group. Neonatal AB0 hemolytic disease with
type B0 incompatibility was significantly associated with a higher hemolysis  rate with no
difference  in  the  incidence  of  severe  hyperbilirubinemia compared to  A0 incompatibility.
Hemolysis and anemia were also less frequent in the A0 group. In neonatal AB0 hemolytic
disease,  it  has been shown that  neonatal  blood group A or B has no major  effect  on the
intensity of neonatal jaundice, but the risk of hemolysis is higher in case of B0 incompatibility
[17]. A similar study was conducted by Kaplan et al., on a group of 164 newborns. In this
trial, significantly more infants with the B0 group developed hyperbilirubinemia in the first 24
hours than their  A0 counterparts.  The age at  which the first  total  bilirubin above the 95 th
percentile was recorded was earlier among the B0 infants. Similarly, there was a tendency to
start phototherapy earlier in newborns with B0 group. The reasons for the markedly increased
severity of jaundice in the B0 subgroup are not clear. Maternal factors, including varying
levels of anti-A or anti-B immunoglobulin G, can influence the degree of hemolysis,  and
changes in IgG distribution can affect macrophage phagocytosis red blood cells. The results of
this study indicate that  heterospecific newborns with blood group B0 are at a higher risk of
hyperbilirubinemia than their A0 counterparts [19].
A 13-year study by Christensen et al., analyzed the results for 42529 newborns, with a
control group consisting of 29729 newborns with blood type 0. Those with blood group A or
B, born to mothers with group 0, exhibited higher levels of total bilirubin in the first 10 days
after birth than those in control group. Moreover, newborns in group B had slightly higher
levels of total bilirubin than newborns in group A. It was found that newborns in group A or
B, born to mothers in group 0, did not develop bilirubin levels exceeding 25 mg/dL more
often, nor did they  require more frequent admission to hospital for jaundice treatment than
group 0 infants born to women in group 0 [20]. 
NECROTIZING ENTEROCOLITIS (NEC)
Infants with blood groups other than 0 have an increased likelihood of a severe course
of NEC. Significantly increased risk of death due to NEC has been documented in infants
with blood group AB compared to all other blood groups. Intestinal resections in infants with
NEC showed more intense staining of endothelial tissue in blood group A than in B or AB
group [13]. In a study by Thomson et al. carried out on a group of 276 newborns diagnosed
with NEC, there was no statistically significant difference between the sex of newborns who
died of NEC and those who survived, but newborns who died of NEC had accordingly lower
birth weight, and newborns of lower gestational age with AB blood were crucially more likely
to die from NEC. A significant difference in survival in the group of AB newborns results not
only  from the  disproportionate  frequency of  their  deaths  (43%),  but  also  from the  short
survival time. Even compared to any other individual blood group, newborns with blood type
AB remained at a remarkably increased risk of NEC mortality, but the risk was greatest if they
were born to a mother with blood type A or AB. Researchers suggest that the presence of both
A and B antigens in newborns from the AB blood group increases the chance of an immune
response and may explain the much worse prognosis in the NEC [21]. 
CONCLUSIONS
Based on the provided studies, it can be concluded that blood groups influence the
occurrence of pregnancy complications and neonatal diseases and may affect their severity.
Due to the detected correlations between the AB0 group system and these conditions and
complications,  it  is  possible  to  increase  the  diagnostic  vigilance  in  pregnant  women  and
newborns  with a specific  blood group. It  seems important  that  the influence on the birth
weight depending on the blood group was proven — the lowest weight was presented by
newborns born of mothers with blood group B. However, the influence of external factors
significantly influences the birth weight of newborns, which results in the fact that in the case
of nicotinism during pregnancy lower birth weight occurs in newborns whose mothers had
blood type A.
Moreover, the analyzed literature shows that children with the AB blood group have
higher  risk  of  developing  neonatal  diseases,  such as  NEC and  neutropenia. Furthermore,
neonatal conditions with a proven increased risk of disease due to blood type should be more
closely monitored  in  clinical  practice.  For  example,  more  rigorous  monitoring  should  be
implemented in newborns with blood group B born to mothers with blood group 0 due to the
increased risk of hemolytic disease in newborns [17]. However, due to the limited number of
publications about neonatal diseases, further research on this concern will be required. 
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